19-35359104-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005304.5(FFAR3):c.214A>G(p.Met72Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000609 in 1,608,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M72T) has been classified as Uncertain significance.
Frequency
Consequence
NM_005304.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000797 AC: 12AN: 150600Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000150 AC: 37AN: 247424Hom.: 0 AF XY: 0.000127 AC XY: 17AN XY: 134286
GnomAD4 exome AF: 0.0000590 AC: 86AN: 1457564Hom.: 0 Cov.: 34 AF XY: 0.0000593 AC XY: 43AN XY: 725304
GnomAD4 genome AF: 0.0000796 AC: 12AN: 150712Hom.: 0 Cov.: 30 AF XY: 0.0000680 AC XY: 5AN XY: 73560
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.214A>G (p.M72V) alteration is located in exon 2 (coding exon 1) of the FFAR3 gene. This alteration results from a A to G substitution at nucleotide position 214, causing the methionine (M) at amino acid position 72 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at